Actavis Testosterone Drug Flouts 6 Patents, Eli Lilly Says
Eli Lilly & Co. hit generic drugmaker Actavis Inc. and its subsidiaries with a suit Tuesday in Indiana federal court claiming that the company infringed six patents covering Eli Lilly's Axiron,...To view the full article, register now.
Already a subscriber? Click here to view full article